# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-16-722504
Filing Date
2016-09-28
Accepted
2016-09-28 09:00:59
Documents
29
Period of Report
2016-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d251504d8k.htm | 8-K | 14726
2 | EX-99.1 | d251504dex991.htm | EX-99.1 | 19949
3 | GRAPHIC | g251504ex99_1s10g1.jpg | GRAPHIC | 168877
4 | GRAPHIC | g251504ex99_1s11g1.jpg | GRAPHIC | 188274
5 | GRAPHIC | g251504ex99_1s12g1.jpg | GRAPHIC | 290552
6 | GRAPHIC | g251504ex99_1s13g1.jpg | GRAPHIC | 250105
7 | GRAPHIC | g251504ex99_1s14g1.jpg | GRAPHIC | 160042
8 | GRAPHIC | g251504ex99_1s15g1.jpg | GRAPHIC | 106578
9 | GRAPHIC | g251504ex99_1s16g1.jpg | GRAPHIC | 137007
10 | GRAPHIC | g251504ex99_1s17g1.jpg | GRAPHIC | 146741
11 | GRAPHIC | g251504ex99_1s18g1.jpg | GRAPHIC | 213465
12 | GRAPHIC | g251504ex99_1s19g1.jpg | GRAPHIC | 87104
13 | GRAPHIC | g251504ex99_1s1g1.jpg | GRAPHIC | 166191
14 | GRAPHIC | g251504ex99_1s20g1.jpg | GRAPHIC | 114712
15 | GRAPHIC | g251504ex99_1s21g1.jpg | GRAPHIC | 167252
16 | GRAPHIC | g251504ex99_1s22g1.jpg | GRAPHIC | 109462
17 | GRAPHIC | g251504ex99_1s23g1.jpg | GRAPHIC | 152781
18 | GRAPHIC | g251504ex99_1s24g1.jpg | GRAPHIC | 116509
19 | GRAPHIC | g251504ex99_1s25g1.jpg | GRAPHIC | 123897
20 | GRAPHIC | g251504ex99_1s26g1.jpg | GRAPHIC | 110358
21 | GRAPHIC | g251504ex99_1s27g1.jpg | GRAPHIC | 163360
22 | GRAPHIC | g251504ex99_1s2g1.jpg | GRAPHIC | 390867
23 | GRAPHIC | g251504ex99_1s3g1.jpg | GRAPHIC | 309812
24 | GRAPHIC | g251504ex99_1s4g1.jpg | GRAPHIC | 145363
25 | GRAPHIC | g251504ex99_1s5g1.jpg | GRAPHIC | 122145
26 | GRAPHIC | g251504ex99_1s6g1.jpg | GRAPHIC | 122815
27 | GRAPHIC | g251504ex99_1s7g1.jpg | GRAPHIC | 199853
28 | GRAPHIC | g251504ex99_1s8g1.jpg | GRAPHIC | 130983
29 | GRAPHIC | g251504ex99_1s9g1.jpg | GRAPHIC | 151279
| Complete submission text file | 0001193125-16-722504.txt |  | 6300764

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 161905802
SIC: 2836 Biological Products, (No Diagnostic Substances)